Cargando…

Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report

INTRODUCTION: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jun, Xu, Gang, Feng, Congrui, Chen, Yuluo, Kang, Yanhong, Liu, Feng, Ma, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254568/
https://www.ncbi.nlm.nih.gov/pubmed/32443324
http://dx.doi.org/10.1097/MD.0000000000020129
_version_ 1783539566803681280
author Zhao, Jun
Xu, Gang
Feng, Congrui
Chen, Yuluo
Kang, Yanhong
Liu, Feng
Ma, Wei
author_facet Zhao, Jun
Xu, Gang
Feng, Congrui
Chen, Yuluo
Kang, Yanhong
Liu, Feng
Ma, Wei
author_sort Zhao, Jun
collection PubMed
description INTRODUCTION: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caused by various diseases, resulting in water retention and refractory hyponatremia. However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported. We describe an unusual case of malignant hyperthermia and refractory hyponatremia due to trihexyphenidyl adverse reaction. PATIENT CONCERNS: Fifty-five-year-old male with pneumonia presented with malignant hyperthermia and refractory hyponatremia has a history of Parkinson's disease. DIAGNOSIS: Early considerations related the described hyperthermia findings to the manifestations of pneumonia. However, the last findings were due to trihexyphenidyl adverse reaction. INTERVENTIONS: Broad-spectrum antibiotics, oral and intravenous supplement of concentrated sodium chloride, drug, and physical cooling. OUTCOMES: The patient survived. During the 3-month follow up, the patient was no recurrence of fever or hyponatremia. CONCLUSION: High fever and SIADH can be a rare adverse reaction to trihexyphenidyl. Therefore, possible drug factors should be considered in the case. Consideration of other possible causes can improve early diagnosis and treatment of patients with fever of unknown origins.
format Online
Article
Text
id pubmed-7254568
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72545682020-06-15 Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report Zhao, Jun Xu, Gang Feng, Congrui Chen, Yuluo Kang, Yanhong Liu, Feng Ma, Wei Medicine (Baltimore) 4200 INTRODUCTION: Drug-induced fever is easy to overlook in respiratory departments. High fever is a rare side effect of trihexyphenidyl, which can be used clinically to treat Parkinson's disease. Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is a group of clinical syndromes caused by various diseases, resulting in water retention and refractory hyponatremia. However, pneumonia combined with malignant hyperthermia and SIADH has rarely been reported. We describe an unusual case of malignant hyperthermia and refractory hyponatremia due to trihexyphenidyl adverse reaction. PATIENT CONCERNS: Fifty-five-year-old male with pneumonia presented with malignant hyperthermia and refractory hyponatremia has a history of Parkinson's disease. DIAGNOSIS: Early considerations related the described hyperthermia findings to the manifestations of pneumonia. However, the last findings were due to trihexyphenidyl adverse reaction. INTERVENTIONS: Broad-spectrum antibiotics, oral and intravenous supplement of concentrated sodium chloride, drug, and physical cooling. OUTCOMES: The patient survived. During the 3-month follow up, the patient was no recurrence of fever or hyponatremia. CONCLUSION: High fever and SIADH can be a rare adverse reaction to trihexyphenidyl. Therefore, possible drug factors should be considered in the case. Consideration of other possible causes can improve early diagnosis and treatment of patients with fever of unknown origins. Wolters Kluwer Health 2020-05-15 /pmc/articles/PMC7254568/ /pubmed/32443324 http://dx.doi.org/10.1097/MD.0000000000020129 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4200
Zhao, Jun
Xu, Gang
Feng, Congrui
Chen, Yuluo
Kang, Yanhong
Liu, Feng
Ma, Wei
Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
title Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
title_full Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
title_fullStr Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
title_full_unstemmed Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
title_short Trihexyphenidyl induced malignant hyperthermia in a patient with Parkinson's disease complicated with pneumonia: A case report
title_sort trihexyphenidyl induced malignant hyperthermia in a patient with parkinson's disease complicated with pneumonia: a case report
topic 4200
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254568/
https://www.ncbi.nlm.nih.gov/pubmed/32443324
http://dx.doi.org/10.1097/MD.0000000000020129
work_keys_str_mv AT zhaojun trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport
AT xugang trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport
AT fengcongrui trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport
AT chenyuluo trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport
AT kangyanhong trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport
AT liufeng trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport
AT mawei trihexyphenidylinducedmalignanthyperthermiainapatientwithparkinsonsdiseasecomplicatedwithpneumoniaacasereport